Stockscreener 앱 받기
15.65
1.14%
-0.18
시간 외 거래:
15.68
0.03
+0.19%
전일 마감가:
$15.83
열려 있는:
$15.79
하루 거래량:
893.21K
Relative Volume:
0.52
시가총액:
$1.88B
수익:
$59.61M
순이익/손실:
$-262.14M
주가수익비율:
-3.9923
EPS:
-3.92
순현금흐름:
$-247.49M
1주 성능:
-0.89%
1개월 성능:
+5.32%
6개월 성능:
+22.27%
1년 성능:
+48.62%
1일 변동 폭
$15.45
$15.96
1주일 범위
$15.43
$16.27
52주 변동 폭
$8.03
$17.75
Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile
명칭
Arcutis Biotherapeutics Inc
전화
805-418-5006
주소
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
ARQT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics Inc
|
15.65 | 1.90B | 59.61M | -262.14M | -247.49M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 개시 | Goldman | Neutral |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-28 | 개시 | Jefferies | Buy |
| 2024-01-03 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-10-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2023-10-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-09-07 | 개시 | Needham | Buy |
| 2022-03-17 | 개시 | Goldman | Buy |
| 2021-06-30 | 개시 | Mizuho | Buy |
| 2021-05-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-25 | 개시 | Cowen | Outperform |
| 2020-02-25 | 개시 | Goldman | Neutral |
| 2020-02-25 | 개시 | Guggenheim | Buy |
모두보기
Arcutis Biotherapeutics Inc 주식(ARQT)의 최신 뉴스
Can you recover from losses in Arcutis Biotherapeutics Inc.July 2025 Breakouts & Precise Trade Entry Recommendations - Newser
Arcutis Biotherapeutics Inc. stock retracement – recovery analysis2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-08-27 10:54:22 - Newser
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year? - ca.finance.yahoo.com
What’s next for Arcutis Biotherapeutics Inc. stock priceWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
Will Arcutis Biotherapeutics Inc. price bounce be sustainableMarket Movers & Fast Entry High Yield Tips - Newser
What technical models suggest about Arcutis Biotherapeutics Inc.’s comeback2025 Analyst Calls & Risk Managed Investment Signals - Newser
3 Biotech Catalysts Present Major Opportunity - Investing.com
Combining machine learning predictions for Arcutis Biotherapeutics Inc.Watch List & Fast Entry Momentum Alerts - Newser
Using data filters to optimize entry into Arcutis Biotherapeutics Inc.Analyst Downgrade & Safe Capital Growth Plans - Newser
Three Biotech Companies to Watch: Boston Scientific, Arcutis Biotherapeutics, and Incyte Corporation - AInvest
Will Arcutis Biotherapeutics Inc. continue its uptrendWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Sentiment Turns Positive on Arcutis Biotherapeutics Inc. — Reversal Ahead getLinesFromResByArray error: size == 0 - metrotimes.co.kr
Will breakout in Arcutis Biotherapeutics Inc. lead to full recoveryJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
Live market analysis of Arcutis Biotherapeutics Inc.Weekly Market Outlook & Daily Price Action Insights - Newser
Applying big data sentiment scoring on Arcutis Biotherapeutics Inc.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
3 Biotech Catalysts Present Major Opportunity - MarketBeat
Published on: 2025-08-24 08:42:48 - Newser
Is Arcutis Biotherapeutics Inc. stock showing strong momentumTrade Exit Report & Low Risk Entry Point Tips - theviewers.co.kr
What recovery options are there for Arcutis Biotherapeutics Inc.2025 Short Interest & Free Growth Oriented Trading Recommendations - Newser
Applying chart zones and confluence areas to Arcutis Biotherapeutics Inc.Breakout Watch & Low Drawdown Momentum Ideas - Newser
What momentum shifts mean for Arcutis Biotherapeutics Inc.Quarterly Performance Summary & Community Trade Idea Sharing Platform - Newser
How moving averages guide Arcutis Biotherapeutics Inc. tradingEarnings Risk Summary & Reliable Price Breakout Signals - Newser
Arcutis: ZORYVE's Multi-Indication Momentum And Margin Expansion Justify A Bullish Re-Rate - Seeking Alpha
Arcutis’ ZORYVE Receives AAD Recommendation for Adult Atopic Dermatitis - MSN
Will Arcutis Biotherapeutics Inc. announce a stock splitWeekly Trend Summary & Daily Technical Forecast Reports - theviewers.co.kr
Can Arcutis Biotherapeutics Inc. maintain sales growthTreasury Yields & Technical Pattern Recognition Alerts - theviewers.co.kr
Arcutis Biotherapeutics Inc. May Be Forming Higher Low — Chartwatchers AlertWatch List & Weekly High Return Opportunities - classian.co.kr
How volatile is Arcutis Biotherapeutics Inc. stockShare Buyback & Free Low Drawdown Momentum Trade Ideas - kpenews.com
Can Arcutis Biotherapeutics Inc. stock double in the next year2025 Investor Takeaways & Reliable Entry Point Alerts - theviewers.co.kr
Arcutis Biotherapeutics Officer Sells Shares to Cover Tax Obligations - TradingView
Is Arcutis Biotherapeutics Inc. the Top Chart Pick This WeekWeekly Investment Report & Weekly Top Stock Performers List - beatles.ru
Smart tools for monitoring Arcutis Biotherapeutics Inc.’s price action2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
Arcutis Biotherapeutics Inc. Recovers — But Is It Sustainable2025 Pullback Review & AI Based Buy/Sell Signal Reports - 더경남뉴스
Tick level data insight on Arcutis Biotherapeutics Inc. volatilityPortfolio Value Summary & Short-Term Swing Trade Alerts - Newser
Arcutis Biotherapeutics Inc. Stock Lags Behind Sector BenchmarksMarket Growth Review & Weekly Chart Analysis and Trade Guides - beatles.ru
Arcutis Biotherapeutics Announces Participation in Upcoming Investor Conferences - AInvest
Arcutis to Present at Upcoming Investor Conferences - MarketScreener
Immuno-Dermatology Leader Arcutis Lines Up Triple Conference Presence: Citi, Morgan Stanley & HC Wainwright - Stock Titan
AI Tools Suggest Arcutis Biotherapeutics Inc. May Outperform This WeekJuly 2025 Big Picture & Risk Adjusted Buy and Sell Alerts - beatles.ru
Will Arcutis Biotherapeutics Inc. bounce back from current supportJobs Report & Growth Oriented Trading Recommendations - Newser
Analyzing recovery setups for Arcutis Biotherapeutics Inc. investorsJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
Is Arcutis Biotherapeutics Inc. a defensive stockEarnings Overview Summary & Real-Time Stock Entry Alerts - thegnnews.com
Is Arcutis Biotherapeutics Inc. still worth holding after the dipJuly 2025 WrapUp & Daily Profit Focused Stock Screening - Newser
Is Arcutis Biotherapeutics Inc. trending in predictive chart modelsJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser
Forecasting Arcutis Biotherapeutics Inc. price range with options data2025 Market Sentiment & Breakout Confirmation Trade Signals - Newser
Published on: 2025-08-16 20:04:51 - Newser
Identifying reversal signals in Arcutis Biotherapeutics Inc.July 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Why is Arcutis Biotherapeutics Inc. stock going upQuarterly Growth Report & Weekly Momentum Picks - thegnnews.com
Arcutis Biotherapeutics Inc. Stages Intraday Comeback — Trend Change2025 Market WrapUp & Capital Efficient Trading Techniques - 선데이타임즈
Arcutis Biotherapeutics Inc (ARQT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):